RHHBF News and Press, Roche Holding AG Bearer Shares

2026-04-09 14:00:00 ET Investment Overview AbbVie Inc. ( ABBV ), the North Chicago, Illinois-based Pharma giant, is expected to report its Q1 2026 earnings around April 29th - in just under three weeks' time.... Read the full article on Seeking Alpha For further ...

2026-04-09 08:11:28 ET More on C4 Therapeutics, Roche Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both) Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline - Slideshow Roche Falters In A K...

2026-04-07 12:20:21 ET Read the full article on Seeking Alpha For further details see: SCD: Unique CEF Could Be Well-Positioned To Outperform In The Current Environment

2026-04-07 12:03:13 ET Investment Overview Towards the end of January this year, I upgraded my rating on Amgen Inc. ( AMGN ) stock from a Hold (issued in a note from February 2025 ) to a Buy, noting that the Thousand Oaks, California-based Pharma giant: has gro...

2026-04-07 07:30:24 ET More on AbbVie, Roche Holding AbbVie: A High 2026 Earnings Bar, But Shares Are Attractive On Valuation AbbVie: Strong 2026 Outlook, Expect Dividend Increases Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both) ...

2026-03-31 12:28:35 ET More on Pfizer, Amgen, etc. Novo Nordisk: Why I Still Find It An Interesting Opportunity Pfizer: Why Wall Street Habitually Overestimates Target Price Why Pfizer Remains A Strong Buy In 2026 FDA issues warning for Amgen's Tavneos follow...

2026-03-27 12:01:34 ET Investment Overview The stock of Palo Alto, California based Kodiak Sciences Inc. ( KOD ) soared in value yesterday, reaching a high of $75 per share (market cap of $2.43bn), as the company announced positive results from its GLOW2 Phase 3 superiority stud...

2026-03-25 09:15:22 ET Introduction Back when I last covered Pfizer ( PFE ), I highlighted the company's peer-leading drug pipeline, strong cash flow and attractive valuation despite the medium-term patent cliff and broader macro headwinds.... Read the full article on ...

2026-03-20 12:48:43 ET More on Roche Holding Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both) Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline - Slideshow Roche Falters In A Key Breast...

2026-03-18 13:57:48 ET Intro: Has Roche Just Eclipsed Eli Lilly In The Battle For AI Drug Development Supremacy? Read the full article on Seeking Alpha For further details see: Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)